Featuring the researcher cast out for investigating his institution’s predatory publishing habits, the end of the replication crisis, and how to have your say on Plan S.
A new reference site from Medical Publishing Insights and Practices (MPIP) aims to educate its users on the ins and outs of open access as part of its commitment to improving research transparency in pharma. With open access everywhere nowadays, it is very important to know what it is and how it works. However, this … Continue reading MPIP launches new open access toolkit
Featuring peer reviewing robots, the debate over the definition of academic freedom and the scary side of preprints.
Featuring the ways publishers can help authors to escape admin work, researchers’ protests against Plan S and a new tool to assist authors to meet open access policy requirements.
Featuring the newest adherents to Plan S, how to make sure your data are re-useable and whether or not open access policies actually work.
This Open Access Week 2018 special edition of the Open Pharma digest features an interactive dashboard of open access data, the cost of open access publishing for research funders, and the latest on Plan S.
Featuring the Royal Society’s plan to combat the replication crisis, a new peer review tool for BMC journals, and the Open Pharma podcast!
Open access is a fantastic opportunity to make science accessible to all. Find out how to get all of the benefits without fearing the predators in our new podcast!
Featuring an interview with the architect of Plan S, the legal case being brought against ResearchGate, and a systematic review on the open access citation advantage.
Featuring the open access citation advantage for research into poverty-related disease, Finland’s decision to join Plan S, and how ORCID can help the pharmaceutical industry.